We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
NRG Energy
NRG
$22.6B
| $1.57M | ﹤0.01% |
42,094
-512,320
| -92% | -$17.4M |
|
1027
Aramark
ARMK
$15.2B
| $1.57M | ﹤0.01% |
50,620
-2,452
| -5% | -$66.8K |
|
1028
Vornado Realty Trust
VNO
$6.5B
| $1.56M | ﹤0.01% |
86,263
-19,574
| -18% | -$288K |
|
1029
NCR Voyix
VYX
$982M
| $1.56M | ﹤0.01% |
100,835
+1,491
| +2% | +$21.5K |
|
1030
SiriusPoint
SPNT
$2.84B
| $1.55M | ﹤0.01% |
+171,434
| New | +$1.57M |
|
1031
Texas Instruments
TXN
$238B
| $1.53M | ﹤0.01% |
8,523
+242
| +3% | +$41.7K |
|
1032
Cerence
CRNC
$355M
| $1.53M | ﹤0.01% |
52,486
-8,508
| -14% | -$233K |
|
|
NGM
1033
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.52M | ﹤0.01% |
585,485
+412,097
| +238% | +$1.47M |
|
1034
Landstar System
LSTR
$5.74B
| $1.5M | ﹤0.01% |
7,777
+1,636
| +27% | +$296K |
|
1035
Sprott Physical Gold
PHYS
$15.3B
| $1.49M | ﹤0.01% |
100,000
+20,000
| +25% | +$309K |
|
1036
Olin
OLN
$1.94B
| $1.49M | ﹤0.01% |
29,004
+310
| +1% | +$16.5K |
|
1037
First Industrial Realty Trust
FR
$8.14B
| $1.49M | ﹤0.01% |
28,252
+2,832
| +11% | +$148K |
|
1038
Crown Holdings
CCK
$12.2B
| $1.48M | ﹤0.01% |
17,073
+17,013
| +28,355% | +$1.4M |
|
1039
AdaptHealth
AHCO
$788M
| $1.47M | ﹤0.01% |
120,586
-53,099
| -31% | -$592K |
|
1040
Regal Rexnord
RRX
$9.94B
| $1.47M | ﹤0.01% |
9,522
-271
| -3% | -$36.9K |
|
1041
Synchrony
SYF
$24.4B
| $1.46M | ﹤0.01% |
43,174
+10,996
| +34% | +$336K |
|
1042
Darling Ingredients
DAR
$10.3B
| $1.46M | ﹤0.01% |
22,912
-3,085
| -12% | -$188K |
|
1043
Toro Company
TTC
$8.74B
| $1.46M | ﹤0.01% |
14,330
-552
| -4% | -$56.6K |
|
1044
Suburban Propane Partners
SPH
$1.13B
| $1.46M | ﹤0.01% |
98,366
-9,160
| -9% | -$139K |
|
1045
LPL Financial
LPLA
$26.2B
| $1.44M | ﹤0.01% |
6,616
-28,983
| -81% | -$5.8M |
|
1046
Marcus & Millichap
MMI
$1.18B
| $1.44M | ﹤0.01% |
45,613
-284,394
| -86% | -$8.79M |
|
1047
Ingles Markets
IMKTA
$1.57B
| $1.41M | ﹤0.01% |
17,083
-8,318
| -33% | -$716K |
|
1048
Dorian LPG
LPG
$2.48B
| $1.41M | ﹤0.01% |
54,867
+567
| +1% | +$12.9K |
|
1049
Flowserve
FLS
$9.19B
| $1.4M | ﹤0.01% |
37,788
+4,901
| +15% | +$170K |
|
1050
NerdWallet
NRDS
$602M
| $1.39M | ﹤0.01% |
147,814
-3,711
| -2% | -$41.9K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.